Latest news

Daily Snap - 1. October 2025

Daily Snap - 1. October 2025

Joachim Eeckhout
Star Therapeutics raises $125M to push next-gen bleeding disorder drug to market

Star Therapeutics raises $125M to push next-gen bleeding disorder drug to market

Eduardo Longoria
Crystalys launches with $205M to bring next-gen gout drug global

Crystalys launches with $205M to bring next-gen gout drug global

Eduardo Longoria
Daily Snap - 30. September 2025

Daily Snap - 30. September 2025

Joachim Eeckhout
Moonlake shares collapse after mixed trial results for key immune drug

Moonlake shares collapse after mixed trial results for key immune drug

Eduardo Longoria
Genmab acquires Merus in $8B deal, betting on late-stage cancer therapy

Genmab acquires Merus in $8B deal, betting on late-stage cancer therapy

Eduardo Longoria
Daily Snap - 29. September 2025

Daily Snap - 29. September 2025

Joachim Eeckhout
Eli Lilly expands biotech footprint with new San Diego incubator

Eli Lilly expands biotech footprint with new San Diego incubator

Eduardo Longoria
Biogen exits AAV gene therapy, cuts staff and shifts strategy

Biogen exits AAV gene therapy, cuts staff and shifts strategy

Eduardo Longoria
Daily Snap - 26. September 2025

Daily Snap - 26. September 2025

Joachim Eeckhout
Merck licenses Evaxion’s AI-discovered vaccine in $592M deal

Merck licenses Evaxion’s AI-discovered vaccine in $592M deal

Eduardo Longoria
Lilly halts muscle-sparing obesity drug trial, citing strategy shift

Lilly halts muscle-sparing obesity drug trial, citing strategy shift

Eduardo Longoria
FirstBack
12345678
Next Last